Glycolysis Metabolites and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Trial is a research paper published in Metabolites (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01HL118264
Instituto de Salud Carlos III
Grant: CNIC-06/2007
Instituto de Salud Carlos III
Grant: RTIC G03/140
Instituto de Salud Carlos III
Grant: CIBER 06/03
Instituto de Salud Carlos III
Grant: PI06-1326
Instituto de Salud Carlos III
Grant: PI07-0954
Instituto de Salud Carlos III
Grant: PI11/02505
Instituto de Salud Carlos III
Grant: SAF2016-80532
Instituto de Salud Carlos III
Grant: SAF2009-12304
Instituto de Salud Carlos III
Grant: AGL2010-22319-C03-03
Instituto de Salud Carlos III
Grant: THEMATIC NETWORK "PREDIMED", RD 06/0045
Generalitat Valenciana
Grant: PROMETEO 17/2017
Generalitat Valenciana
Grant: ACOMP2010-181
Generalitat Valenciana
Grant: AP111/10
Generalitat Valenciana
Grant: AP-042/11
Generalitat Valenciana
Grant: ACOM2011/145
Generalitat Valenciana
Grant: ACOMP/2012/190
Generalitat Valenciana
Grant: ACOMP/2013/159
Generalitat Valenciana
Grant: ACOMP/213/165
Instituto de Salud Carlos III
Grant: THEMATIC NETWORK "PREDIMED", RD 06/0045
FWCI
0.69
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords